Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Contingent Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹3.00 Cr₹0.40 Cr₹15 Cr₹8.00 Cr₹1.20 Cr

What is the latest Contingent Liabilities ratio of NATCO PHARMA ?

The latest Contingent Liabilities ratio of NATCO PHARMA is ₹3.00 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹3.00 Cr
Mar2024₹0.40 Cr
Mar2023₹15 Cr
Mar2022₹8.00 Cr
Mar2021₹1.20 Cr

How is Contingent Liabilities of NATCO PHARMA Trending?

Years Contingent Liabilities % Change
Mar2025 ₹3.00 Cr
650.00
Mar2024 ₹0.40 Cr
-97.26
Mar2023 ₹15 Cr
82.50
Mar2022 ₹8.00 Cr
566.67
Mar2021 ₹1.20 Cr -

Compare Contingent Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹17,700.5 Cr 10.7% 18.3% 21.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

10.7%

18.3%

21.8%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses